product Name：GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT)
  • Gadolinium, (1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7)-; Gadolinium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane; Gd(DO3A); Gd-DO 3A; 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, gadolinium complex; Gadolinium, (1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-kappaN1, kappaN4,kappaN7,kappaN10,kappaO1,kappaO4,kappaO7)-; 2-[4,10-bis(2-oxido-2-oxo-ethyl)-1,4,10-triaza-7-azanidacyclododec-1-yl]acetate; gadolinium(+3) cation; gadolinium(III) 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate
  • 112188-16-6
  • C14H22GdN4O6
  • 499.5982
  • InChI=1/C14H25N4O6.Gd/c19-12(20)9-16-3-1-15-2-4-17(10-13(21)22)6-8-18(7-5-16)11-14(23)24;/h1-11H2,(H,19,20)(H,21,22)(H,23,24);/q-1;+3/p-3
  • GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) 112188-16-6
  • 617.6°C at 760 mmHg
  • 327.3°C
  • 7.68E-17mmHg at 25°C